Research News and Research

RSS

Today's opinions: Rep. Ryan's plan to aid Medicare; The burden on health law supporters in Va.; Evaluating Medicare actuary's estimates

Only in Washington could the government raid one entitlement program to finance a brand-new one and still claim that deficits have been reduced and entitlements have been reformed (Rep. Paul Ryan, 8/13).

13 Aug 2010

Hospitals' 'bad debts' grow as even insured patients have trouble paying medical bills

A "local hospital group says the fastest-growing part of what hospitals call 'bad debt' -- basically, uncollectible bills -- is money owed by patients who have insurance. As employers dump costs onto workers, so now are workers dumping costs onto hospitals. Because of rising deductibles and cost-sharing rules, patients are increasingly faced with bills that would have been unusual for someone with insurance a few years ago. Growing numbers of them can't pay, or won't. Total bad debt grew 12 percent, from $490 million in fiscal 2007 to nearly $550 million in fiscal 2008, at 36 area hospitals that responded to a 2009 survey by the Delaware Valley Healthcare Council of HAP, a hospital association that released the data this week. But bad debt from insured patients grew twice as fast: 28 percent, from $76 million to $97 million."

13 Aug 2010

Researchers identify second type of complete sporadic disease

A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy, as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease was reported in the 1920s. The landmark finding from the National Prion Disease Pathology Surveillance Center at Case Western Reserve University is published in the August issue of Annals of Neurology.

13 Aug 2010

Dyadic second-quarter 2010 total revenue decreases to $2.2 million

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the second quarter ended June 30, 2010.

13 Aug 2010

KHN column: Medicaid rescissions worse than private insurers

On Tuesday, members of the House of Representatives interrupted their August vacation and returned to Washington to vote on a bill to send money to the states. The issue that dominated the news was saving the jobs of teachers, police officers and other public employees. But most of the money allocated will prevent the states from cutting off health benefits for millions of people.

13 Aug 2010

Quick-Med Technologies, Biosara sign development agreement

Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has signed a development agreement with Biosara Corporation, a medical device company targeting wound dressings for major medical and healthcare providers, along with the multi-billion dollar organized sports athlete markets.

13 Aug 2010

Management of therapy-resistant schizophrenia

The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment.

13 Aug 2010

SANUWAVE second-quarter revenues decrease to $117,000

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, today reported financial results for the three and six months ended June 30, 2010 and provided a business update.

13 Aug 2010

Soligenix’s net loss for second-quarter 2010 decreases to $1,577,000

Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the second quarter of 2010.

13 Aug 2010

Catalyst second-quarter net loss decreases to $1,328,541

Catalyst Pharmaceutical Partners, Inc. today announced its financial results for the second quarter and six months ended June 30, 2010.

13 Aug 2010

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

The Cardiovascular Research Foundation has announced that in addition to the previously announced late breaking clinical trials and first reports, a series of additional featured trials will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium. These trials will focus on a wide range of significant topics in interventional cardiovascular medicine. TCT 2010 will take place September 21 - 25 in Washington, DC.

13 Aug 2010

Trubion Pharmaceuticals signs definitive merger agreement with Emergent BioSolutions

Trubion Pharmaceuticals, Inc. today announced the signing of a definitive merger agreement with Emergent BioSolutions Inc., in which Emergent has agreed to acquire Trubion. Under the terms of the agreement, each share of Trubion common stock will be converted into the right to receive an upfront payment of $1.365 per share in cash and 0.1641 shares of Emergent BioSolutions common stock.

13 Aug 2010

ISW calls upon states to consider community-based programs as treatment for sex offenders

A recent analysis conducted by the Associated Press revealed that the 20 states with civil commitment laws will spend nearly $500 million in 2010 to incarcerate only 5,000 offenders. According to experts at the Boston-based Institute for Sexual Wellness (ISW), states concerned with how to pay for these programs over the long term should investigate community-based programs. Not only are such programs available at a fraction of the cost of civil commitment, but they are demonstrating high success in preventing recidivism.

13 Aug 2010

Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million

Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.

13 Aug 2010

Derma Sciences second-quarter net sales increase 14% to $13.2 million

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2010.

13 Aug 2010

First Edition: August 13, 2010

Today's headlines explore a variety of health policy issues, ranging from consumer protections regarding benefit rights to the cost of electronic medical records.

13 Aug 2010

Insurers' actions mirror credit card companies' interest rate increases ahead of new consumer rights

Consumer Watchdog and the Center for Media and Democracy today asked the Obama administration to investigate how the major for-profit health insurance companies are reducing their proportion of spending on health care in advance of health reform, even as premiums spike upward. In a letter to Health and Human Services chief Kathleen Sebelius, the groups compared insurers' actions to those of credit card companies, which spiked annual interest rates last year in advance of new federal regulations that would curb corporate abuses.

13 Aug 2010

Chemspec second-quarter total sales increase to record RMB266.8 million

Chemspec International Limited, a leading China-based contract manufacturer of highly-engineered specialty chemicals, today announced its unaudited financial results for the second quarter ended June 30, 2010.

13 Aug 2010

University of Alberta and Health Canada announce study on Residential Indoor Air Quality

Researchers at the University of Alberta are trying to help clear the air about the levels of air pollutants in people's homes.

13 Aug 2010

Achillion second-quarter net loss increases to $6.4 million

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and six months ended June 30, 2010. For the second quarter of 2010, the Company reported a net loss of $6.4 million, compared with a net loss of $6.1 million for the same period last year. Cash, cash equivalents and marketable securities as of June 30, 2010 were $19.5 million.

13 Aug 2010

Research News and Research

Today's opinions: Rep. Ryan's plan to aid Medicare; The burden on health law supporters in Va.; Evaluating Medicare actuary's estimates

Hospitals' 'bad debts' grow as even insured patients have trouble paying medical bills

Researchers identify second type of complete sporadic disease

Dyadic second-quarter 2010 total revenue decreases to $2.2 million

KHN column: Medicaid rescissions worse than private insurers

Quick-Med Technologies, Biosara sign development agreement

Management of therapy-resistant schizophrenia

SANUWAVE second-quarter revenues decrease to $117,000

Soligenix’s net loss for second-quarter 2010 decreases to $1,577,000

Catalyst second-quarter net loss decreases to $1,328,541

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

Trubion Pharmaceuticals signs definitive merger agreement with Emergent BioSolutions

ISW calls upon states to consider community-based programs as treatment for sex offenders

Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million

Derma Sciences second-quarter net sales increase 14% to $13.2 million

First Edition: August 13, 2010

Insurers' actions mirror credit card companies' interest rate increases ahead of new consumer rights

Chemspec second-quarter total sales increase to record RMB266.8 million

University of Alberta and Health Canada announce study on Residential Indoor Air Quality

Achillion second-quarter net loss increases to $6.4 million

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence